Editas Medicine (EDIT) EBT Margin Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,688.00 |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10.15 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 383,431.00 |
| Dec 31, 2024 | -11,691.00 |
| Sep 30, 2024 | -10.10 Mn |
| Jun 30, 2024 | -1.18 Mn |
| Mar 31, 2024 | -497,698.00 |
| Dec 31, 2023 | 89,782.00 |
| Sep 30, 2023 | 13.18 Mn |
| Jun 30, 2023 | -55,144.00 |
| Mar 31, 2023 | 26,090.00 |
| Dec 31, 2022 | -59,692.00 |
| Sep 30, 2022 | -13.21 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 13,060.00 |
| Dec 31, 2021 | 24,256.00 |
| Sep 30, 2021 | -64,563.00 |
| Jun 30, 2021 | -1.43 Mn |
| Mar 31, 2021 | -8,590.00 |
| Dec 31, 2020 | -26,734.00 |
| Sep 30, 2020 | 86,986.00 |
| Jun 30, 2020 | 116,108.00 |
| Mar 31, 2020 | 62,425.00 |
| Dec 31, 2019 | 10,187.00 |
| Sep 30, 2019 | -75,027.00 |
| Jun 30, 2019 | -91,976.00 |
| Mar 31, 2019 | -61,906.00 |
| Sep 30, 2018 | 32,161.00 |
| Jun 30, 2018 | 33,028.00 |
| Mar 31, 2018 | 378,772.00 |
| Sep 30, 2017 | 175,881.00 |
| Jun 30, 2017 | -29,545.00 |
| Mar 31, 2017 | -237,958.00 |
| Dec 31, 2016 | -281,442.00 |
| Sep 30, 2016 | -107,698.00 |
| Jun 30, 2016 | 568,332.00 |